ScholarIQanswers from OpenAlex

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients

PaperCitations, authors & open-access status

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients have?

ScholarIQcitation count

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients published?

ScholarIQyear

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients has 2010 year in the ScholarIQ index.

What is the open-access status of Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients?

ScholarIQoa status

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients has closed oa status in the ScholarIQ index.

What is the DOI of Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients?

ScholarIQdoi

The DOI for Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients is on the source record.

What is the PMID of Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients?

ScholarIQpmid

The PMID for Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients is on the source record.

What is the OpenAlex record for Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients?

ScholarIQopenalex

The OpenAlex for Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial